Literature DB >> 21301794

Glutamine: pleiotropic roles in tumor growth and stress resistance.

Naval P Shanware1, Andrew R Mullen, Ralph J DeBerardinis, Robert T Abraham.   

Abstract

Tumors and tumor cell lines rapidly consume the amino acid glutamine (Gln) and use it to supply metabolic pathways that support cell growth and proliferation. Much of the research regarding the relationship between glutamine metabolism and cancer is based on the premise that this abundant nutrient represents an important driver of tumor cell anabolism. However, Gln's influence in cell biology and cancer extends far beyond its use as a carbon and nitrogen source for the structural components of dividing cells. Gln is truly a multipurpose nutrient, feeding many additional pathways that boost the ability of cells to communicate with each other and to cope with stress by oncogenic signaling and by the tumor microenvironment. A number of recent reports have highlighted these "non-anabolic" functions of Gln metabolism in regulating cell survival, oxidative stress resistance, signal transduction, and autophagy. Here, we review some of these findings and discuss their relevance to tumor biology and the potential for cancer therapy.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21301794     DOI: 10.1007/s00109-011-0731-9

Source DB:  PubMed          Journal:  J Mol Med (Berl)        ISSN: 0946-2716            Impact factor:   4.599


  43 in total

1.  Glutaminolysis yields a metabolic by-product that stimulates autophagy.

Authors:  Christina H Eng; Robert T Abraham
Journal:  Autophagy       Date:  2010-10-20       Impact factor: 16.016

2.  Acid treatment of melanoma cells selects for invasive phenotypes.

Authors:  Raymond E Moellering; Kvar C Black; Chetan Krishnamurty; Brenda K Baggett; Phillip Stafford; Matthew Rain; Robert A Gatenby; Robert J Gillies
Journal:  Clin Exp Metastasis       Date:  2008-02-27       Impact factor: 5.150

3.  Glutamine targeting inhibits systemic metastasis in the VM-M3 murine tumor model.

Authors:  Laura M Shelton; Leanne C Huysentruyt; Thomas N Seyfried
Journal:  Int J Cancer       Date:  2010-11-15       Impact factor: 7.396

4.  Evidence that glutamine, not sugar, is the major energy source for cultured HeLa cells.

Authors:  L J Reitzer; B M Wice; D Kennell
Journal:  J Biol Chem       Date:  1979-04-25       Impact factor: 5.157

5.  Mitochondrial metabolism and ROS generation are essential for Kras-mediated tumorigenicity.

Authors:  Frank Weinberg; Robert Hamanaka; William W Wheaton; Samuel Weinberg; Joy Joseph; Marcos Lopez; Balaraman Kalyanaraman; Gökhan M Mutlu; G R Scott Budinger; Navdeep S Chandel
Journal:  Proc Natl Acad Sci U S A       Date:  2010-04-26       Impact factor: 11.205

6.  Glucose addiction of TSC null cells is caused by failed mTORC1-dependent balancing of metabolic demand with supply.

Authors:  Andrew Y Choo; Sang Gyun Kim; Matthew G Vander Heiden; Sarah J Mahoney; Hieu Vu; Sang-Oh Yoon; Lewis C Cantley; John Blenis
Journal:  Mol Cell       Date:  2010-05-28       Impact factor: 17.970

Review 7.  Why do cancers have high aerobic glycolysis?

Authors:  Robert A Gatenby; Robert J Gillies
Journal:  Nat Rev Cancer       Date:  2004-11       Impact factor: 60.716

Review 8.  Q's next: the diverse functions of glutamine in metabolism, cell biology and cancer.

Authors:  R J DeBerardinis; T Cheng
Journal:  Oncogene       Date:  2009-11-02       Impact factor: 9.867

Review 9.  Glutamine homeostasis and mitochondrial dynamics.

Authors:  José M Matés; Juan A Segura; José A Campos-Sandoval; Carolina Lobo; Lorenzo Alonso; Francisco J Alonso; Javier Márquez
Journal:  Int J Biochem Cell Biol       Date:  2009-03-17       Impact factor: 5.085

10.  Deficiency in glutamine but not glucose induces MYC-dependent apoptosis in human cells.

Authors:  Mariia Yuneva; Nicola Zamboni; Peter Oefner; Ravi Sachidanandam; Yuri Lazebnik
Journal:  J Cell Biol       Date:  2007-07-02       Impact factor: 10.539

View more
  90 in total

Review 1.  Cellular metabolism and disease: what do metabolic outliers teach us?

Authors:  Ralph J DeBerardinis; Craig B Thompson
Journal:  Cell       Date:  2012-03-16       Impact factor: 41.582

2.  Heat Shock Factor 1 Epigenetically Stimulates Glutaminase-1-Dependent mTOR Activation to Promote Colorectal Carcinogenesis.

Authors:  Jiaqiu Li; Ping Song; Tingting Jiang; Dongjun Dai; Hanying Wang; Jie Sun; Liyuan Zhu; Wenxia Xu; Lifeng Feng; Vivian Y Shin; Helen Morrison; Xian Wang; Hongchuan Jin
Journal:  Mol Ther       Date:  2018-04-14       Impact factor: 11.454

3.  ErbB2 activation upregulates glutaminase 1 expression which promotes breast cancer cell proliferation.

Authors:  Shuo Qie; Clarissa Chu; Weihua Li; Chenguang Wang; Nianli Sang
Journal:  J Cell Biochem       Date:  2014-03       Impact factor: 4.429

4.  A return to cancer metabolism.

Authors:  Gregg L Semenza
Journal:  J Mol Med (Berl)       Date:  2011-02-08       Impact factor: 4.599

5.  Mitochondrial GPT2 plays a pivotal role in metabolic adaptation to the perturbation of mitochondrial glutamine metabolism.

Authors:  Minjoong Kim; Jihye Gwak; Sunsook Hwang; Seungyeon Yang; Seung Min Jeong
Journal:  Oncogene       Date:  2019-02-14       Impact factor: 9.867

6.  FOXM1 promotes the warburg effect and pancreatic cancer progression via transactivation of LDHA expression.

Authors:  Jiujie Cui; Min Shi; Dacheng Xie; Daoyan Wei; Zhiliang Jia; Shaojiang Zheng; Yong Gao; Suyun Huang; Keping Xie
Journal:  Clin Cancer Res       Date:  2014-03-14       Impact factor: 12.531

7.  Tumor microenvironment derived exosomes pleiotropically modulate cancer cell metabolism.

Authors:  Hongyun Zhao; Lifeng Yang; Joelle Baddour; Abhinav Achreja; Vincent Bernard; Tyler Moss; Juan C Marini; Thavisha Tudawe; Elena G Seviour; F Anthony San Lucas; Hector Alvarez; Sonal Gupta; Sourindra N Maiti; Laurence Cooper; Donna Peehl; Prahlad T Ram; Anirban Maitra; Deepak Nagrath
Journal:  Elife       Date:  2016-02-27       Impact factor: 8.140

8.  Understanding tumor anabolism and patient catabolism in cancer-associated cachexia.

Authors:  Alejandro Schcolnik-Cabrera; Alma Chávez-Blanco; Guadalupe Domínguez-Gómez; Alfonso Dueñas-González
Journal:  Am J Cancer Res       Date:  2017-05-01       Impact factor: 6.166

9.  Suppression of Hepatocellular Carcinoma by Inhibition of Overexpressed Ornithine Aminotransferase.

Authors:  Ehud Zigmond; Ami Ben Ya'acov; Hyunbeom Lee; Yoav Lichtenstein; Zvi Shalev; Yoav Smith; Lidya Zolotarov; Ehud Ziv; Rony Kalman; Hoang V Le; Hejun Lu; Richard B Silverman; Yaron Ilan
Journal:  ACS Med Chem Lett       Date:  2015-05-29       Impact factor: 4.345

Review 10.  Chemical metabolic inhibitors for the treatment of blood-borne cancers.

Authors:  Martin Villalba; Nuria Lopez-Royuela; Ewelina Krzywinska; Moeez G Rathore; Robert A Hipskind; Houda Haouas; Nerea Allende-Vega
Journal:  Anticancer Agents Med Chem       Date:  2014-02       Impact factor: 2.505

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.